<PAGE>
                                                                    EXHIBIT 23.2

               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

    We consent to the reference to our firm under the caption "Experts" and to
the use of our report dated October 6, 2000 with respect to the financial
statements of ImmGenics Pharmaceuticals Inc., in the Registration Statement
(Form S-1) and related Prospectus of Abgenix, Inc. for the registration of
shares of its common stock issuable upon the exchange of special shares of
ImmGenics Pharmaceuticals Inc.

                                          /s/ ERNST & YOUNG LLP
                                          Chartered Accountants

Vancouver, Canada
November 9, 2000



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission